Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2020-04-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 5535I' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership thresholds being crossed (15.14% down to 14.94%). Therefore, the most specific classification is Major Shareholding Notification (MRQ).
2020-04-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1496 characters) and contains the header 'RNS Number : 2948I'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of brief, time-sensitive regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory announcement category, RNS (Regulatory Filings), as per the provided definitions and the presence of the RNS identifier.
2020-03-31 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1479 characters) and contains the header 'RNS Number : 2916I'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a general regulatory announcement that does not fit the specific categories like Earnings Release (ER), Annual Report (10-K), or Dividend Notice (DIV). Since it is a miscellaneous regulatory announcement provided via RNS, the most appropriate classification is the general Regulatory Filings category.
2020-03-31 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document contains an 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a type of market operational announcement. Since this is a general regulatory announcement provided via the RNS service and does not fit into the specific categories like ER, 10-K, or DIV, the most appropriate classification is the general regulatory filing fallback category.
2020-03-31 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1479 characters) and contains the header 'RNS Number : 2284I'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a general regulatory announcement concerning market operations rather than a specific financial report (like 10-K, IR, or ER) or a specific corporate action (like DIV or DIRS). Since it is a general regulatory announcement provided via RNS, and it doesn't fit neatly into the other specific categories, the most appropriate classification is the general Regulatory Filings fallback category.
2020-03-31 English
£1.5m Subscrip'n to fund R&D pipeline- replacement
Regulatory Filings Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 0090I) on March 30, 2020. The content details a 'Subscription to raise £1.5 million' through the issue of new ordinary shares to two parties, including an institutional investor (Lanstead) and a director. This clearly describes a financing activity and capital structure change. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it is an RNS announcement, the core subject matter is the financing event itself, not just the announcement of a report, making CAP more specific than the general RNS fallback. The document also mentions a replacement of a previous announcement, which is common for material corporate actions.
2020-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.